Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18024701 | GENETIC MODIFICATIONS FOR XENOTRANSPLANTATION | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18724856 | Fusion Protein of Anti-Transferrin Receptor Antibody and Physiologically Active Protein for Safe Gene Therapy | Non-Final OA | JCR PHARMACEUTICALS CO., LTD. |
| 18483264 | PREPARATION AND THERAPEUTIC USE OF 3D-CULTURED FIBROBLASTS | Non-Final OA | FIBROBIOLOGICS |
| 18280218 | MANUFACTURING DEVICE OF ARTIFICIAL SKIN USING CELLS DIFFERENTIATED FROM INDUCED PLURIPOTENT STEM CELLS | Non-Final OA | CLECELL, CO. LTD. |
| 18358490 | POTENTIATION OF BONE MARROW CELL ACTIVITY BY COADMINISTRATION WITH OXYTOCIN | Non-Final OA | CREATIVE MEDICAL TECHNOLOGIES, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy